Mays Cancer Center Annual Report Magazine
2022 issue
A year of transformative progress
UT Health San Antonio's Joe R. and Teresa Lozano Long School of Medicine Dean Robert Hromas, MD, identifies four areas of focus of the Mays Cancer Center in its quest to end cancer for communities in South Texas and beyond.
The biology of cancer
Mays Cancer Center researchers are making significant strides in understanding risk factors and conditions that cause cancers to develop and progress and assessing impacts on the health and recovery of patients with cancer.
Promising compound kills range of hard-to-treat cancers
Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.
New discoveries in pediatric cancer research
The findings from recent research studies in pediatric cancer offer hope for drug development.
Disparities discussed at San Antonio Breast Cancer Symposium
Researchers from the Mays Cancer Center at UT Health San Antonio presented results of multiple lines of study during the San Antonio Breast Cancer Symposium, operated in conjunction with the American Association of Cancer Research.
How COVID-19 vaccines affect patients with cancer
Mays Cancer Center researchers are studying how the immune system responds to the novel coronavirus vaccine in patients with cancer, and why many Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.
The science of cancer
The Mays Cancer Center is advancing cancer care and awareness among diverse populations, increasing their participation in cancer research, leading the conversation about the need for health equity and pursuing partnerships and alliances to increase diversity in clinical trials.
Boosting Hispanic representation in cancer research
The Mays Cancer Center has been named a founding partner of the Advancing Inclusive Research Site Alliance, a coalition of clinical research sites seeking to advance the representation of diverse patient populations in clinical trials.
First lady Jill Biden visits Mays Cancer Center
In February 2022, first lady Jill Biden toured the Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Hispanics.
The intersection of research and practice
The Mays Cancer Center is testing new treatments to enhance and extend the life of patients with cancer and translating leading-edge research into new drugs and technology-assisted procedures that are improving patient health and recovery.
NIH grant to boost ovarian cancer drug development
The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.